POLR2F
DNA-directed RNA polymerases I, II, and III subunit RPABC2
Also known as: HRBP14.4, RPAB2_HUMAN, RPB6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P61218
- Gene
- POLR2F
- Ensembl
- ENSG00000100142
- Chromosome
- 22
- Canonical length
- 127 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center
OverviewNCBI Gene
This gene encodes the sixth largest subunit of RNA polymerase II, the polymerase responsible for synthesizing messenger RNA in eukaryotes. In yeast, this polymerase subunit, in combination with at least two other subunits, forms a structure that stabilizes the transcribing polymerase on the DNA template. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
127 residues, UniProt reviewed canonical sequence.
>P61218|POLR2F
1 MSDNEDNFDG DDFDDVEEDE GLDDLENAEE EGQENVEILP SGERPQANQK RITTPYMTKY
61 ERARVLGTRA LQIAMCAPVM VELEGETDPL LIAMKELKAR KIPIIIRRYL PDGSYEDWGV
121 DELIITDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POLR2F can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 112 nTPM
Expression across tissuesHPA
Tissue
- liver: 112 nTPM
- skeletal muscle: 106 nTPM
- spinal cord: 96 nTPM
- heart muscle: 87 nTPM
- midbrain: 80 nTPM
- choroid plexus: 77 nTPM
Single-cell type
- oligodendrocytes: 628 nCPM
- extravillous trophoblasts: 377 nCPM
- early primary spermatocytes: 341 nCPM
- hepatocytes: 332 nCPM
- esophageal suprabasal cells: 330 nCPM
- migrating cytotrophoblasts: 304 nCPM
Immune cell
- eosinophil: 141 nTPM
- neutrophil: 124 nTPM
- plasmacytoid DC: 124 nTPM
- basophil: 120 nTPM
- NK-cell: 114 nTPM
- T-reg: 104 nTPM
Brain region
- white matter: 170 nTPM
- cerebral cortex: 112 nTPM
- basal ganglia: 110 nTPM
- hypothalamus: 108 nTPM
- medulla oblongata: 102 nTPM
- thalamus: 99 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.89
- DepMap mean gene effect
- -1.98
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- transcription by RNA polymerase I
- transcription by RNA polymerase II
- tRNA transcription by RNA polymerase III
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA polymerase, subunit omega/Rpo6/RPB6
- Archaeal Rpo6/eukaryotic RPB6 RNA polymerase subunit
- DNA-directed RNA polymerase, 14-18kDa subunit, conserved site
- DNA-directed RNA polymerase, subunit RPB6
- RPB6/omega subunit-like superfamily
- RNA polymerase Rpb6
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POLR2F in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POLR2F as an antibody target. Whether an autoantibody or antibody against POLR2F could matter depends on whether native POLR2F is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POLR2F is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POLR2F as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...